COLA CEO Doug Beigel was interviewed recently by ADVANCE Magazine about what becoming the first private accreditor to receive ISO certification has meant to COLA’s ability to serve its clients.
A copy of the interview can be found here.
The Centers for Medicare and Medicaid Services (CMS) has issued a proposed rule to retract the so-called physician signature requirement for clinical diagnostic lab testing. Originally part of the 2011 Physician Fee Schedule final rule, the policy would have required the signature of a physician or qualified non-physician practitioner on a requisition for tests paid…
As the Obama White House and Congressional Republicans debate the debt ceiling and budget situations, possible impacts to Medicare funding continue to be part of the discussion. One of the proposals said to be on the front burner involves imposing a 20 percent Medicare Part B patient copay on clinical lab services.. Lab tests are…
In its July 2011 update to the list of waived tests, CMS added three new devices approved by the FDA for this purpose. CPT CODE EFFECTIVE DATE DESCRIPTION 82274QW, G0328QW January 1, 2011 Polymedco Poly Stat OC-light FOB Test 87804QW January 10, 2011 BTNX, Inc. Rapid Response Influenza A Test Cassette 87804QW January…
For COLA’s Assistant Accreditation Division Manager, accreditation is her latest stop in a varied lab career
If you would like to follow Doug directly for more timely updates and industry perspectives, you can follow/subscribe to him at the following links: Thoughts on COLA Cares Week 2011 By Douglas Beigel, Chief Executive Officer, COLA At COLA, we’re all part of the same work community. Together we help promote patient safety by…
COLA staff participated in a pair of webinars during the month of June. First, COLA partnered with ADVANCE Magazine on a webinar providing an overview of the state of waived testing. Its purpose was to give lab professionals some practical advice on how to conduct this testing in a quality manner. COLA Chief Marketing Officer…
The Centers for Disease Control, which has developed educational materials encouraging healthcare professionals to follow good lab practices when performing waived testing, will soon unveil another tool. In an email message to the members of its Clinical Laboratory Improvement Advisory Committee, CDC is seeking physicians willing to “pilot test” a recently developed online training module…
Doug Beigel recently announced that pathologist and COLA surveyor John Daly, M.D. has been named COLA’s new Chief Medical Officer (CMO). Daly’s new position is the latest milestone in a long and distinguished career as a pathologist and a laboratory scientist. He retired from the Duke University School of Medicine in 2009. Dr. Daly was…
COLA CEO Doug Beigel recently paid a visit to Maryland Congressman Elijah Cummings in his office at the Rayburn House Office Building on Capitol Hill. Cummings, who represents COLA’s Columbia-based headquarters in the U. S. House of Representatives, serves as Ranking Member of the Committee on Oversight and Government Reform. He also has a long…
